ABOUT ME

Dr. Clayton has been active in advanced materials and medicinal chemistry for over 25 years.  His labs develop novel chemistries touching peoples lives daily.  He is a partner of an analytical laboratory in Gilford, New Hampshire specializing in separation and identification of cannabinoids, medical device testing, and environmental testing.

As Director at EFI, he is responsible for leading product development teams commercializing hardware and chemistry to fuel the shift in manufacturing from analog to digital. 

Flash Chromatography
Flash Chromatography

Working up novel compounds

press to zoom
Terry and the girls
Terry and the girls

press to zoom
International colleagues
International colleagues

Shanghai vendor trips

press to zoom
Flash Chromatography
Flash Chromatography

Working up novel compounds

press to zoom
1/9

Prior to joining EFI, Dr. Clayton was Vice President at Chromatic Technologies and led an explosion of innovation and development. As VP he was responsible for the product roadmap, stage gate, project management, and intellectual property. His synthetic team specialized in design and complex purification of microencapsulation, leuco dye synthesis, photochromic and thermochromic materials. He worked closely with key clients worldwide (CPG and government agencies), Operations and global CMO's to develop and produce new products. Product categories include plastic masterbatch, paste inks for lithographic dry and wet offset, textile inks, writing instruments, gravure and flexographic inks for packaging in waterbased, heatset, solvent, and radiation curable markets.


Before CTI, Dr. Clayton led product development and the international expansion for Quad Graphics. He led a global team to build a European inks and coating manufacturing plant in Warsaw, Poland. His team developed inks and coatings for the most productive analog and digital printers in the world. He was responsible for developing and production of pigment dispersions, heatset offset, sheetfed inks, solvent based inkjet, water based inkjet inks, UV/LED/radiation curable inkjet inks, adhesives, coatings and conductive materials for printed electronics in North and South America and Europe.

In graduate school, Dr. Clayton’s work was featured on a cover story in Current Medicinal Chemistry. He developed drugs for the brain and central nervous system. His work has been cited over 750 times. His collaborators include Harvard Medical School, Medical School of Vienna, Columbia University, Johns Hopkins University, among others...

Dr. Clayton has a Doctorate in organic chemistry, an MS, and dual BS. Currently, he is adjunct faculty member at the University of Wisconsin-Milwaukee. Key Executives graduate of Harvard Business School, Editorial Board member of Current Research in Chemical Sciences and enjoys consulting.

Cook Group

EDUCATION

RESEARCH INTERESTS

Inks & Coatings

Development and Commercialization

2012

Harvard Business School

Key Executives Program

2D & 3D Printing

Designing systems to replace analog

Drug Discovery

Compounds targeting the central nervous system

Sustainable Chemistry

Developing renewables to replace petro-based

2011

University of Wisconsin

PhD - Organic Chemistry

2005

University of Wisconsin

MS - Chemistry